Dupont Capital Management Corp sells 28,551 Amicus Therapeutics, Inc. shares (NASDAQ:FOLD)
According to the most recent Form 13F filing that Amicus Therapeutics, Inc. made with the SEC, during the third quarter of 2018, Dupont Capital Management …
FOLD stock news
Campbell, Bradley L. Amicus Therapeutics, Inc. (NASDAQ:FOLD) stock is sold for 11,700 dollars.
On January 9, Bradley L. Campbell, currently serving as the Chief Executive Officer of Amicus Therapeutics, Inc. (NASDAQ: FOLD), sold 11,700 shares of the company’s …